Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

MGTXMeiraGTx, LLCInvite-only sign-up

Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia

Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands

0Calmworry score, out of 100

No strong warning signs right now. The score counts warning signs; it is not a prediction.

Why this score

No warning signs right now. That's why the score is 0.

Score over time

Stage
Phase 2
Patients
276 (planned)
Started
Aug 2, 2024
Main results expected
Feb 2032
Fully finished
Feb 2032
Results posted
not yet

What counts as success

The trial's main goal(s), called the “primary outcome.”

  • Number of participants with study drug-related adverse events and serious adverse events

    Measured over: From study start until Month 60 post-treatment

Changes Tremor has spotted

No changes since Tremor started watching this trial.
Show details (technical version)

Score inputs

  • none

Raw record changes

  • none yet

Trial ID NCT06544798 · record last updated 2025-10-16 · checked 2026-11-09 15:47 UTC

See the official record on ClinicalTrials.gov (NCT06544798) ↗